» Articles » PMID: 23082760

Transfer of Growth Factor Receptor MRNA Via Exosomes Unravels the Regenerative Effect of Mesenchymal Stem Cells

Overview
Journal Stem Cells Dev
Date 2012 Oct 23
PMID 23082760
Citations 189
Authors
Affiliations
Soon will be listed here.
Abstract

Bone marrow-mesenchymal stem cells (BM-MSC) ameliorate renal dysfunction and repair tubular damage of acute kidney injury by locally releasing growth factors, including the insulin-like growth factor-1 (IGF-1). The restricted homing of BM-MSC at the site of injury led us to investigate a possible gene-based communication mechanism between BM-MSC and tubular cells. Human BM-MSC (hBM-MSC) released microparticles and exosomes (Exo) enriched in mRNAs. A selected pattern of transcripts was detected in Exo versus parental cells. Exo expressed the IGF-1 receptor (IGF-1R), but not IGF-1 mRNA, while hBM-MSC contained both mRNAs. R- cells lacking IGF-1R exposed to hBM-MSC-derived Exo acquired the human IGF-1R transcript that was translated in the corresponding protein. Transfer of IGF-1R mRNA from Exo to cisplatin-damaged proximal tubular cells (proximal tubular epithelial cell [PTEC]) increased PTEC proliferation. Coincubation of damaged PTEC with Exo and soluble IGF-1 further enhanced cell proliferation. These findings suggest that horizontal transfer of the mRNA for IGF-1R to tubular cells through Exo potentiates tubular cell sensitivity to locally produced IGF-1 providing a new mechanism underlying the powerful renoprotection of few BM-MSC observed in vivo.

Citing Articles

The potential ameliorative effect of mesenchymal stem cells-derived exosomes on cerebellar histopathology and their modifying role on PI3k-mTOR signaling in rat model of autism spectrum disorder.

Elsherif R, Mm Abdel-Hafez A, Hussein O, Sabry D, Abdelzaher L, Bayoumy A J Mol Histol. 2025; 56(1):65.

PMID: 39760823 DOI: 10.1007/s10735-024-10335-w.


Mesenchymal Stem Cells-Derived Small Extracellular Vesicles and Their Validation as a Promising Treatment for Chondrosarcoma in a 3D Model in Vitro.

Romano E, Perut F, Avnet S, Di Pompo G, Silvestri S, Roffo F Biotechnol Bioeng. 2024; 122(3):667-676.

PMID: 39690717 PMC: 11808436. DOI: 10.1002/bit.28909.


Extracellular Vesicles in Pathophysiology: A Prudent Target That Requires Careful Consideration.

Shahi S, Kang T, Fonseka P Cells. 2024; 13(9.

PMID: 38727289 PMC: 11083420. DOI: 10.3390/cells13090754.


Allogeneic bone marrow mesenchymal stem cell-derived exosomes alleviate human hypoxic AKI-on-a-Chip within a tight treatment window.

Cam S, Ciftci E, Gurbuz N, Altun B, Korkusuz P Stem Cell Res Ther. 2024; 15(1):105.

PMID: 38600585 PMC: 11005291. DOI: 10.1186/s13287-024-03674-8.


How does exosome cause diabetes?.

Hu F, Yu Y, Xu H Hormones (Athens). 2024; 23(3):385-393.

PMID: 38233729 DOI: 10.1007/s42000-024-00525-2.


References
1.
Pereira R, Halford K, OHara M, Leeper D, Sokolov B, Pollard M . Cultured adherent cells from marrow can serve as long-lasting precursor cells for bone, cartilage, and lung in irradiated mice. Proc Natl Acad Sci U S A. 1995; 92(11):4857-61. PMC: 41806. DOI: 10.1073/pnas.92.11.4857. View

2.
Capelli C, Domenghini M, Borleri G, Bellavita P, Poma R, Carobbio A . Human platelet lysate allows expansion and clinical grade production of mesenchymal stromal cells from small samples of bone marrow aspirates or marrow filter washouts. Bone Marrow Transplant. 2007; 40(8):785-91. DOI: 10.1038/sj.bmt.1705798. View

3.
Yuan A, Farber E, Rapoport A, Tejada D, Deniskin R, Akhmedov N . Transfer of microRNAs by embryonic stem cell microvesicles. PLoS One. 2009; 4(3):e4722. PMC: 2648987. DOI: 10.1371/journal.pone.0004722. View

4.
Fevrier B, Raposo G . Exosomes: endosomal-derived vesicles shipping extracellular messages. Curr Opin Cell Biol. 2004; 16(4):415-21. DOI: 10.1016/j.ceb.2004.06.003. View

5.
Camussi G, Deregibus M, Bruno S, Cantaluppi V, Biancone L . Exosomes/microvesicles as a mechanism of cell-to-cell communication. Kidney Int. 2010; 78(9):838-48. DOI: 10.1038/ki.2010.278. View